A Machine Vision‐Guided Microphysiological Platform With Automated Microfluidics Enables Longitudinal Biomarker Monitoring and Emulation of Translationally Relevant Exposure Scenarios
Year: 2026
Type: article
Abstract: Low success rates in clinical drug development can be largely attributed to the poor predictive power of existing preclinical models. Microphysiological systems (MPS) have greatly advanced in vitro modeling; however, current platforms do not adequately support long-term sampling and often fail to recapitulate nutrient and drug exposure dynamics. To address these limitations, we established a machine vision-guided MPS with real-time fluidic control that enables fully automated periodic sampling with high temporal resolution, media replenishment, and programmable dosing, allowing for the simulation of dynamic nutritional or pharmacological exposure scenarios. We showcase the system's capability by emulating physiological insulin profiles and repeated-dose pharmacokinetic exposures over multiple weeks. Furthermore, pharmacokinetically accurate acetaminophen exposure in 3D primary human liver spheroids mimicking an acute overdose rapidly induced liver toxicity, as evidenced by aminotransferase release, cytokine secretion and a drop in cellular ATP. In contrast, dose-equivalent constant exposure patterns did not elicit detectable hepatotoxicity. Mechanistically, targeted proteomics of sampled supernatants and Cell Painting revealed that toxicity was paralleled by disrupted lipid homeostasis, loss of tight junctions and extracellular matrix remodeling. These results demonstrate the robustness and versatility of the machine vision-guided automated microphysiological platform and underscore the importance of incorporating drug exposure dynamics for mechanistic toxicology.
Source: Advanced Science
DOI: 10.1002/advs.76256
Institutions: Karolinska Institutet, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, University of Tübingen, KTH Royal Institute of Technology, Zhejiang University, Fraunhofer Institute for Translational Medicine and Pharmacology, Second Xiangya Hospital of Central South University, Xiangya Hospital Central South University
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $6,730
Awards: G1240223215, G1268635613, G3142454408, G4107891390, Identifikation neuer therapeutischer Zielstrukturen mit einer chemogenomischen Strategie in primären humanen NASHModellen, G5008169543, G5307063007, G5631231289, Targeting tissue crosstalk to combat non-alcoholic fatty liver disease, Functional human 3D in vitro models as a preclinical screening platform for understanding the hepatotoxicity and liver biodistribution of biologics, G7152249211, G7987758029, Targeting adipose tissue-liver cross talk to combat non-alcoholic fatty liver disease, G8907254087
OpenAlex ID: W7165541925
